BridgeBio Pharma BBIO Preferred Stock
Preferred Stock at other companies
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockValue.
The official record: BridgeBio Pharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BridgeBio Pharma's preferred stock.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BridgeBio Pharma's preferred stock?
- BridgeBio Pharma (BBIO) reported preferred stock of $0 in Q1 2026.
- What does preferred stock mean?
- The value of special shares that have priority over common stock for dividends and asset distribution.
- How do you interpret preferred stock?
- Issuance often signals a need for capital without diluting common shareholders as much as a secondary offering, or a strategic partnership.
- How does preferred stock compare across companies?
- Used by many biotech firms to raise capital from institutional investors with specific protective rights.